A custom botanical blend lets a brand build a formula around its own claims, dosage form and market instead of adapting to an off-the-shelf extract. The path from an idea to a repeatable production batch is predictable if the brief is clear — and expensive if it is not. Here is how an OEM botanical extract project typically runs.
1. The formulation brief
The more precise the brief, the fewer iterations. Include target actives or marker levels, the dosage form (capsule, tablet, powder sachet, liquid, gummy), intended label claims, daily dose and serving size, target market and its regulatory constraints, allergen, vegan, organic or non-GMO requirements, preferred carriers or excluded excipients, sensory constraints (color, taste, odor), target cost and expected volume. If you have an existing formula, share the current spec and what you want to improve.
2. Feasibility and sourcing
Not every combination is stable or soluble in the intended format. This stage checks ingredient availability, whether each active can be standardized to the requested level, interactions between components, and which botanical, fungal or animal-derived ingredients need separate sourcing. It is also where regulatory constraints — novel food status, permitted claims, maximum levels — should be flagged before any lab work starts.
3. Sample and pilot batch
A laboratory sample confirms appearance, taste, solubility and preliminary assay. A pilot batch then tests whether the blend behaves the same at production scale: mixing uniformity, flow, dusting, hygroscopicity and assay homogeneity across the batch. Plan for at least one adjustment cycle; it is normal, and far cheaper than discovering the issue after packaging.
4. Documentation and release criteria
Agree the specification and the COA panel up front: identity, assay method, carriers, heavy metals, pesticides, microbiology, allergens and GMO status, plus a technical data sheet, MSDS and origin statement. Define what happens when a result falls outside spec, and who approves the final release. Confidentiality terms and ownership of the formulation should be settled in writing at this point.
5. Stability, scale-up and repeat orders
Confirm shelf life with real or accelerated stability data appropriate to your market, and lock the raw material origin and extraction parameters so the next order matches the first. Ask what changes trigger a new sample approval — a different harvest season, a new carrier or a changed assay method should all be communicated, not discovered on the COA.
Common causes of delay
- Label claims decided after the formula is fixed.
- Unstated excipient or allergen restrictions.
- A target active level with no named assay method.
- Packaging or dosage form chosen before solubility is tested.
Bera Bio provides OEM customization and tailor-made blends across supplement, food, cosmetic and feed grades, from sourcing through standardized production and documentation. To start a project, send your formulation brief and we will come back with feasibility notes and a sample plan.

